Structure-based design of a decorin mimetic targeting TGF-β1

Abstract Decorin mitigates fibrosis by docking onto transforming growth factor-β1 (TGF-β1), but its dense glycosylation and disulfide-rich caps hinder scalable manufacturing. Here we present miniDec, a 15-kDa decorin mimetic built from leucine-rich repeats 4–6 with newly designed, cysteine-free terminal caps. The aglycosylated construct folds efficiently in E. coli , yields >25 mg L⁻¹ after a two-step purification, and binds TGF-β1 with low-nanomolar affinity. miniDec blocks TGF-β-driven transdifferentiation of human corneal fibroblasts and, when applied topically, reduces corneal opacity, restores corneal surface regularity and accelerates epithelial wound closure in a mouse alkali-burn model, with efficacy comparable to that of full-length decorin at the fixed topical doses tested. The protein is non-cytotoxic to corneal epithelium and stromal cells. This new scaffold overcomes the production hurdles of the native proteoglycan while retaining its anti-fibrotic activity, establishing that decorin’s glycosaminoglycan chain, N-glycans and disulfide-bonded caps are dispensable for anti-fibrotic function in the cornea, and providing a manufacturable route to decorin-based therapy for corneal fibrosis.

Authors

Institutions

Publication Details

Journal
npj Regenerative Medicine
Published
2026-11-17
DOI
https://doi.org/10.1038/s41536-026-00524-4
Primary Topic
Corneal Surgery and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Structure-based design of a decorin mimetic targeting TGF-β1

Sahi Nandini Wuppukondur, Mehmet Şen, Vivien Jane Coulson‐Thomas, Tarsis F. Gesteira et al.
2 links
npj Regenerative Medicine
Corneal Surgery and Treatments
article

Structure-based design of a decorin mimetic targeting TGF-β1

Sahi Nandini Wuppukondur, Mehmet Şen, Vivien Jane Coulson‐Thomas, Tarsis F. Gesteira, Sudhir Verma, Nana Aisha Adams, Eduardo Cilli, Cassidy L. Sheffield, Jacob Leipold, Jinal Patel
article en

Abstract

Abstract Decorin mitigates fibrosis by docking onto transforming growth factor-β1 (TGF-β1), but its dense glycosylation and disulfide-rich caps hinder scalable manufacturing. Here we present miniDec, a 15-kDa decorin mimetic built from leucine-rich repeats 4–6 with newly designed, cysteine-free terminal caps. The aglycosylated construct folds efficiently in E. coli , yields >25 mg L⁻¹ after a two-step purification, and binds TGF-β1 with low-nanomolar affinity. miniDec blocks TGF-β-driven transdifferentiation of human corneal fibroblasts and, when applied topically, reduces corneal opacity, restores corneal surface regularity and accelerates epithelial wound closure in a mouse alkali-burn model, with efficacy comparable to that of full-length decorin at the fixed topical doses tested. The protein is non-cytotoxic to corneal epithelium and stromal cells. This new scaffold overcomes the production hurdles of the native proteoglycan while retaining its anti-fibrotic activity, establishing that decorin’s glycosaminoglycan chain, N-glycans and disulfide-bonded caps are dispensable for anti-fibrotic function in the cornea, and providing a manufacturable route to decorin-based therapy for corneal fibrosis.

npj Regenerative Medicine
University of Delhi (IN), Deen Dayal Upadhyaya College (IN), University of Houston (US)
National Eye Institute
Good health and well-being
Corneal Surgery and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon